High-dose methotrexate prior to simultaneous radiochemotherapy in children with malignant high-grade gliomas

Anticancer Research

Volumn 25, Issue 3 C, 2005, Pages 2583-2587

  Wagner, Sabine ^a   Reinert, Christiane ^a   Schmid, Hans Jörg ^b   Liebeskind, Anne Katrin ^c   Jorch, Norbert ^d   Längler, Alfred ^d   Graf, Norbert ^e   Warmuth Metz, Monika ^f   Pietsch, Thorsten ^g   Peters, Ove ^a   Wolff, Johannes E A ^a,h  

^a Krankenhaus der Barmherzigen Bruder   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

^d Krankenanstalten Gilead ^*  (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITY OF CALGARY   (Canada)

Author keywords

Children; High grade gliomas; Methotrexate; Preradiation chemotherapy

Indexed keywords

METHOTREXATE;

ADULT; ANEMIA; ARTICLE; CANCER GRADING; CANCER SURGERY; CANCER THERAPY; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HUMAN; INFECTION; LEUKOPENIA; LUNG TOXICITY; MALE; PRIORITY JOURNAL; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOMA; HUMANS; MALE; METHOTREXATE; PILOT PROJECTS;

EID: 22944462676     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bertino JR: Karnofsky memorial lecture. Ode to methotrexate. J Clin Oncol 11: 5-14, 1993.
2. Wolff JE, Trilling T, Molenkamp G, Egeler RM and Jurgens H: Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 125: 481-486, 1999.
3. Estlin EJ, Lowis SP and Hall AG: Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia. Br J Haematol 110: 29-40, 2000.
4. Bleyer WA: The clinical pharmacology of methotrexate: new applications of an old drug. Cancer 41: 36-51, 1978.
5. Djerassi I, Kim JS and Reggev A: Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue. Cancer 55: 2741-2747, 1985.
6. Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N and Kuhl J: Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94: 264-271, 2002.
7. Allen JC, Walker R and Rosen G: Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. J Clin Oncol 6: 649-653, 1988.
8. Urban C, Benesch M, Pakisch B, Lackner H, Kerbl R, Schwinger W and Oberbauer R: Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults. J Neurooncol 39: 71-80, 1998.
9. Benesch M, Lackner H, Moser A, Kerbl R, Schwinger W, Oberbauer R, Eder HG, Mayer R, Wiegele K and Urban C: Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas. Pediatr Neurosurg 15:173-180, 2001.
10. Packer RJ, Grossman RI, Rorke LB, Sutton LN, Siegel KR and Littman P: Brain stem necrosis after preradiation high-dose methotrexate. Childs Nerv Syst 1: 355-358, 1985.
11. Wolff JE, Molenkamp G, Westphal S, Pietsch T, Gnekow A, Kortmann RD and Kuehl J: Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme. Cancer 89: 2000.
12. Wolff JE, Westphal S, Molenkamp G, Gnekow A, Warmuth-Metz M, Rating D and Kuehl J: Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 21: 945-949, 2002.
13. Wolff JE, Wagner S, Sindichakis M, Pietsch T, Gnekow A, Kortmann RD, Strater R and Kuehl J: Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study. Anticancer Res 22: 3569-3572, 2002.
14. Mulne AF, Ducore JM, Elterman RD, Friedman HS, Krischer JP, Kun LE, Shuster JJ and Kadota RP: Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 22: 41-44, 2000.
15. Atra A, Pinkerton CR, Bouffet E, Norton A, Hobson R, Imeson JD and Gerrard M: United Kingdom Children Cancer Study Group/Non-Hodgkin Lymphoma Group: Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocols. Eur J Cancer 40: 1346-1350, 2004.
16. Cohen Y, Lossos A and Polliack A: Neurotoxicity with leukoencephalopathy after a single intravenous high dose of methotrexate in a patient with lymphoma. Acta Haematol 107: 185-186, 2002b.
17. Behin A, Hoang-Xuan K, Carpentier AF and Delattre JY: Primary brain tumours in adults. Lancet 361: 323-331, 2003.
18. Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig WD, Klingebiel T, Graf N, Gruhn B, Juergens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M and Reiter A: The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms - a report of the BFM group study NHL-BFM95. Blood, in press.
19. Bode U, Erps M and Schiffer D: 42-hour methotrexate infusions as relapse therapy for childhood malignancies: toxicity and efficacy of 109 infusions. Pediatr Hematol Oncol 4: 15-24, 1987.
20. Levitt M, Mosher MB, DeConti RC, Farber LR, Skeel RT, Marsh JC, Mitchell MS, Papac RJ, Thomas ED and Bertino JR: Improved therapeutic index of methotrexate with "leucovorin rescue". Cancer Res 33: 1729-1734, 1973.
21. Wolfrom C, Hartmann R, Fengler R, Bruhmuller S, Ingwersen A and Henze G: Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 11: 827-833, 1993.
22. Frappaz D, Marec Berhard P, Schell M, Philip T, Vighetto A, Bergeron C, Mottolese C, Buclon M and Carrie C: May preradiation chemotherapy improve survival rate of brainstem gliomas? ISPNO, O59, 2002.
23. Cohen IJ, Kornreich L, Shalitin S, Friling R, Michowitz S, Shuper A and Yaniv I: High dose methotrexate and tamoxifen after radiation in diffuse pontine glioma - a pilot study. SIOP, Porto, P244, 2002.